Returns Chart

Key Stats

Customize

Basic Info

Investment Strategy
The trust seeks total return potential primarily through capital appreciation. There is no guarantee that the investment objectives of the trust will be achieved.
General
Security Type Unit Investment Trust
Oldest Share Symbol F000013KMT
Equity Style Mid Cap/Growth
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Category Index S&P 1500 Health Care TR
Prospectus Objective Specialty - Health
Fund Owner Firm Name SmartTrustĀ®
Broad Asset Class Benchmark Index
^MSWNTR 100.0%

Net Fund Flows Versus Category

1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
No Data Available
1 Month
% Rank: --
-- Category Low
-- Category High
1 Year
% Rank: --
-4.011B Category Low
2.782B Category High
3 Months
% Rank: --
-- Category Low
-- Category High
3 Years
% Rank: --
-- Category Low
-- Category High
6 Months
% Rank: --
-- Category Low
-- Category High
5 Years
% Rank: --
-- Category Low
-- Category High
YTD
% Rank: --
-- Category Low
-- Category High
10 Years
% Rank: --
-- Category Low
-- Category High
Date Unavailable

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of November 24, 2020. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Edit comparables
Name
2013
2014
2015
2016
2017
2018
2019
YTD
--
--
--
--
--
--
--
25.34%
26.68%
4.94%
-0.87%
7.51%
22.40%
-8.71%
27.67%
11.34%
69.15%
34.28%
5.75%
-16.96%
19.10%
-15.51%
35.19%
21.52%
62.31%
29.30%
15.17%
-16.03%
45.83%
-0.15%
58.74%
27.41%
--
--
--
--
--
--
--
4.48%
--
--
--
--
--
--
--
10.28%
As of November 24, 2020.

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (11-24-20) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of November 19, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of November 19, 2020

Asset Allocation

As of November 19, 2020.
Type % Net % Long % Short
Cash 0.00% Upgrade Upgrade
Stock 100.00% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 0.00% Upgrade Upgrade

Top 10 Holdings

Name % Weight Price % Change
Mirati Therapeutics Inc 12.85% 225.46 0.92%
Horizon Therapeutics PLC 9.15% 68.90 -0.20%
ACADIA Pharmaceuticals Inc 7.67% 55.86 2.08%
BeiGene Ltd ADR 7.64% 264.16 3.12%
Reata Pharmaceuticals Inc A 6.41% 151.89 -7.64%
Emergent BioSolutions Inc 5.08% 80.41 1.57%
Neurocrine Biosciences Inc 4.53% 95.12 -0.72%
Hutchison China Meditech Ltd ADR 4.06% 31.06 0.13%
Jazz Pharmaceuticals PLC 3.98% 141.83 -0.70%
Myovant Sciences Ltd 3.85% 21.85 1.82%

Fees & Availability

Fees
Actual 12B-1 Fee --
Actual Management Fee --
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Purchase Details
Open to New Investors Yes
Open to Existing Investors Yes
Minimum Initial Investment Upgrade
Minimum Subsequent Investment Upgrade

Basic Info

Investment Strategy
The trust seeks total return potential primarily through capital appreciation. There is no guarantee that the investment objectives of the trust will be achieved.
General
Security Type Unit Investment Trust
Oldest Share Symbol F000013KMT
Equity Style Mid Cap/Growth
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Category Index S&P 1500 Health Care TR
Prospectus Objective Specialty - Health
Fund Owner Firm Name SmartTrustĀ®
Broad Asset Class Benchmark Index
^MSWNTR 100.0%

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (11-24-20) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of November 19, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of November 19, 2020

Fund Details

Key Dates
Inception Date 5/2/2019
Termination Date 5/4/2021
Last Annual Report Date --
Last Prospectus Date --
Share Classes
F000013KMT --
F000013KMW --
SMHCGX --
Attributes
Enhanced Index Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No